Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 163
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05904938 | Oral Administration of Actitan-F in Paediatric Diarrhoea | ||
| NCT03553108 | A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | ||
| NCT04324437 | eRAPID: Online Symptom Reporting in Lung Cancer | ||
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | ||
| NCT05835349 | Observational Study of Venus P-Valve | ||
| NCT05508750 | Growth and Safety Clinical Trial on a New Infant Formula | ||
| NCT05016024 | Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome. | ||
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | ||
| NCT06073652 | Starter Infant Formula With Synbiotics | ||
| NCT00660673 | Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease | ||
| NCT03606603 | Nutrition Insights Day Asia | ||
| NCT05637515 | Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity | ||
| NCT04125290 | US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) | ||
| NCT04600752 | Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India | ||
| NCT04542057 | A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy | ||
| NCT02953652 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT04840849 | Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults | ||
| NCT03615924 | Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease | ||
| NCT03077477 | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers | ||
| NCT04818801 | Safety, Reactogenicity and Immunogenicity Study of ReCOV | ||
| NCT04167137 | Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants | ||
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) | ||
| NCT04027439 | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT04376554 | Effect of Tebipenem on Normal Human Intestinal Microbiota | ||
| NCT05030831 | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT06716801 | Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain | ||
| NCT06485674 | Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus | ||
| NCT04959799 | Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA) | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer | ||
| NCT02955589 | Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) | ||
| NCT05101187 | Olorofim Aspergillus Infection Study | ||
| NCT05551195 | [Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression] | ||
| NCT03666780 | Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study | ||
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | ||
| NCT05874804 | Carry Life@ UF System Clinical Study | ||
| NCT05264506 | Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive | ||
| NCT03850509 | Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation | ||
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | ||
| NCT07049653 | Anifrolumab Pregnancy Study | ||
| NCT02503033 | A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies | ||
| NCT04091360 | A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease |
